Key result
Mitral valve replacement using a fascia lata valve in a 32-year-old woman with active infective endocarditis resulted in a satisfactory postoperative course and the birth of healthy twins 12 months later.
Why the study?
Does mitral valve replacement with a fascia lata valve improve clinical outcomes in a patient with active infective endocarditis resistant to medical treatment?
Case Report (n=1)
Does mitral valve replacement with a fascia lata valve improve clinical outcomes in a patient with active infective endocarditis resistant to medical treatment?
This case report demonstrates that mitral valve replacement can be a viable and successful treatment for active infective endocarditis resistant to medical therapy.
Infective endocarditis which is resistant to medical treatment is fatal. In a woman of 32 years the mitral valve was replaced, in the presence of active infection, by a fascia lata valve. Her postoperative course was entirely satisfactory. Twelve months after operation, after a normal full-term pregnancy, she gave birth to healthy twins. The place of valvar replacement in the treatment of active infective endocarditis of the mitral valve is discussed.
No takes yet. Share an insight, caveat, or question.
Yacoub et al. (1972) conducted a case report in Active infective endocarditis (n=1). Mitral valve replacement by a fascia lata valve was evaluated on Postoperative course and pregnancy outcome. Mitral valve replacement using a fascia lata valve in a 32-year-old woman with active infective endocarditis resulted in a satisfactory postoperative course and the birth of healthy twins 12 months later.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: